Medicamen Biotech Ltd. — Investor Relations & Filings
Medicamen Biotech Ltd. specializes in the research, development, and manufacturing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities compliant with international quality standards, including WHO-GMP. Its product portfolio encompasses various therapeutic segments such as oncology, cardiology, central nervous system, and anti-infectives, delivered through dosage forms like tablets, capsules, and liquid orals. A significant strategic focus is placed on its specialized oncology division, which develops complex generic formulations. The company serves global markets, leveraging its research and development capabilities to provide high-quality healthcare solutions. Its operations are supported by dedicated R&D centers focused on formulation development and process chemistry.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Change in Management | 2025-08-12 | English | |
| Record Date | 2025-08-12 | English | |
| Outcome of Board Meeting | 2025-08-12 | English | |
| Integrated Filing- Financial | 2025-08-12 | English | |
| Outcome of Board Meeting | 2025-08-12 | English | |
| Outcome of Board Meeting | 2025-08-12 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 42364872 | Change in Management | 2025-08-12 | English | ||
| 42365335 | Record Date | 2025-08-12 | English | ||
| 42367850 | Outcome of Board Meeting | 2025-08-12 | English | ||
| 42368143 | Integrated Filing- Financial | 2025-08-12 | English | ||
| 42368538 | Outcome of Board Meeting | 2025-08-12 | English | ||
| 42373223 | Outcome of Board Meeting | 2025-08-12 | English | ||
| 43930787 | Board Meeting — Financial Results | 2025-08-07 | English | ||
| 43930747 | Board Meeting — Board Meeting Intimation | 2025-08-07 | English | ||
| 42347762 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2025-07-29 | English | ||
| 42347684 | Trading Window | 2025-06-30 | English | ||
| 42341274 | General Updates | 2025-06-03 | English | ||
| 42351011 | Copy of Newspaper Publication | 2025-06-02 | English | ||
| 42370413 | Dividend | 2025-05-30 | English | ||
| 42370443 | Outcome of Board Meeting | 2025-05-30 | English | ||
| 43899534 | Board Meeting — Board Meeting Intimation | 2025-05-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Medicamen Biotech Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61898/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61898 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61898 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61898 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61898}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Medicamen Biotech Ltd. (id: 61898)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.